The FDA has given Northwest Biotherapeutics an open runway to commence several clinical trials, each holding multi-billion dollar market values, all at once, was a major statement of regulatory support in my opinion. In terms of Northwest Biotherapeutics insider trading, its CEO Linda Powers in the past 12 months has purchased 10,809,992 shares of her company's stock, making her the majority stakeholder in the company and bringing her ownership total to roughly 30% of the company's outstanding shares.
THIS is a very strong rally and base. The float is 12 million................. The volume is 13 million and climbing. The 15 million cash payment will go a long way for future developments. This is a milestone for the company ..............
This is going to run just like them...... they are shorted to over sold levels then drove to high. We are in for a good run.
sacrificing small blocks of shares wont work for them. The tree shaking will be followed by big industry moves as money is flowing into the BIO sector lately.
Many ADHD are meth !!!!!!!!!!!!!!!!!!!!! This is different and it is going much higher
Breaking from the heavy load of buyers. Most people know this stock and FIO are down 50% for the year. Its been rough on the storage industry. We see the amount of data double every year from the cloud and video apps. The new chips address consumer and enterprise storage. The best of both worlds most likely to please the buyer. Most understand this and FIO and know they have been shorted . With out the pressure and up trend in place we could reap the rewards of the shorts tricks.